FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and aims at treating attention deficit/hyperactivity syndrome (ADHD). The method of treating attention deficit/hyperactivity syndrome involves administering a therapeutically effective amount of a compound having formula , or its pharmaceutically acceptable salt into a mammal in need thereof, wherein R, R1 and R2 mean hydrogen and x=1. What is also provided is a pharmaceutical composition containing a compound having formula (1), or its pharmaceutically acceptable salt.
EFFECT: using the group of inventions provides the effective treatment of attention deficit/hyperactivity syndrome.
13 cl, 5 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATMENT OF BIPOLAR DISORDER | 2011 |
|
RU2653408C2 |
CRYSTALLINE FORM OF 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND | 2009 |
|
RU2503662C2 |
METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) | 2006 |
|
RU2417077C2 |
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2009 |
|
RU2515612C2 |
COMPOUND FOR USE IN TREATING NEUROGENIC ORTHOSTATIC HYPOTENSION | 2017 |
|
RU2723095C1 |
3-PHENOXYMETHYL-PYRROLIDINE COMPOUNDS | 2010 |
|
RU2535669C2 |
COMPOSITIONS FOR TREATING ABUSE WITH SUBSTANCES CAUSING PAINFUL ADDICTION, AND IMPROVEMENT OF BEHAVIOUR ASSOCIATED WITH ABUSE | 2010 |
|
RU2535046C2 |
1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING COCHLEAR TINNITUS | 2008 |
|
RU2438658C2 |
METHOD OF TREATING FIBROMYALGIA SYNDROME | 2010 |
|
RU2557533C2 |
MIXTURE CONTAINING CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF SCHIZOPHRENIA | 2018 |
|
RU2772465C2 |
Authors
Dates
2015-07-10—Published
2010-11-03—Filed